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Summary 
 
Evolution of the fibroblast growth factor (FGF) - FGF receptor (FGFR) signaling system follows 
closely that of multicellular organisms. The abilities of 9 FGFs (FGFs 1-9; examples of FGF sub-
families -1, -4, -7, -8 and -9) and 7 FGF receptors or isoforms (FGFR1b, 1c, 2b, 2c, 3b, 3c and 4) 
to support signaling in the presence of heparin, a proxy for the cellular heparan sulfate co-receptor, 
were assembled into a network. A connection between two FGFRs was defined as their mutual 
ability to signal with a particular FGF. The network contained a core of 4 receptors (FGFR1c, 2c, 
3c and 4) with complete connectivity and high redundancy. Analysis of the wider network indicated 
that neither FGF-3 nor FGF-7 was well-connected to this core of 4 receptors and, that divergence 
of a precursor of FGF sub-groups 1, 4 and 9 from FGF subgroup 8 may have allowed expansion 
from a 3 member FGFR core signaling system to the 4 member core network. This increases 4-
fold the number of possible signaling combinations. Synchrotron Radiation Circular dichroism 
spectra of the FGFs with heparin revealed no overall common structural change, suggesting 
distinct heparin binding sites throughout the FGFs. The approach provides a potential method of 
identifying agents capable of influencing particular FGF/FGFR combinations, or areas of the 
signaling network for experimental, or therapeutic purposes. 
 
Introduction 
 
The fibroblast growth factors (FGFs) regulate many aspects of embryonic development and adult 
homeostasis. The 22 human FGFs are usually divided into 7 sub-families according to their 
sequence similarities; subfamilies -1, -4, -7, -8, -9, -11 and -19. These correspond broadly to 
certain functions, although the relationships of these remains a matter of debate, though the FGF-
11 subfamily is intracellular and does not interact with extracellular receptors {Itoh, 2004 
 #72;Oulion, 2012 #73}. In humans, the 22 fgf genes encode the ligands and 5 fgfr genes encode 
the cognate membrane receptors, FGFRs. In simpler organisms, less elaborate FGF-FGFR 
signaling systems are evident. For example, in C. elegans, only two fgf genes and one fgfr gene 
have been identified, indicating that the FGF ligand-receptor system expanded during the 
evolutionary process from primitive metazoa to vertebrates {Itoh, 2004 #72;Oulion, 2012 #73}. 
In structural terms, FGFR consist of two to three extracellular immunoglobin (Ig) domains, 
linked by a single transmembrane region to a cytoplasmic domain, which contains a tyrosine 
kinase in FGFR-1 to -4 {Itoh, 2004 #72;Trueb, 2011 #102}. The latter becomes phosphorylated 
following binding of a FGF to the receptor together with its obligatory co-receptor, heparan sulfate 
(HS), which is the carbohydrate portion of cell surface HS proteoglycans (HSPGs). 
Phosphorylation of the cytoplasmic domain leads to downstream signaling events. The FGFR 
signaling system has been implicated in both normal developmental and aberrant processes, and 
the possibility of controlling it remains of great interest for the study and eventual treatment of 
many diseases and to promote tissue repair {Beenken, 2009 #96;Grose, 2005 #86;Presta, 2005 
#85}. Alternative splicing produces receptors with differences in the third Ig domain of FGFR (D3) 
and/or shortened versions, in which the acid box between D1 and D2 is absent. According to the 
crystal structures of FGFs with receptor domains D2 and D3, FGFs bind to D2 and the proximal 
regions of D3 and this may explain the specificity for FGFs between splice variants {Plotnikov, 
2000 #77;Plotnikov, 1999 #76}. FGFRs 1 and 2 exhibit distinct binding properties to heparin 
{Powell, 2002 #79} and the crystal structures of complexes of FGF and FGFR in the presence of 
heparin-derived oligosaccharides provide evidence of direct interaction of the sugar with each 
protein component, albeit in two distinct arrangements {Pellegrini, 2000 #81;Schlessinger, 2000 
#82}. The stimulation of cell proliferation requires the formation of a ternary complex of the FGF, 
FGFR and the HS co-receptor, a requirement demonstrated in vivo {Lin, 1999 #103}. The HS co-
receptor has at least one other key function, since it controls the transport of the FGFs from source 
to targets {Duchesne, 2012 #39}.  
HS, as well as its proxy heparin, are glycosaminoglycan (GAG) polysaccharides with a 
common underlying disaccharide backbone structure, comprising a uronic acid, α-L-iduronic or β-
D-glucuronic acid, linked alternately through a 1-4 linkage to an α-D-glucosamine residue. 
Biosynthesis first generates a polysaccharide chain containing 50 to 100 repeating disaccharides 
of 1, 4 linked β-D-glucuronic acid and α-linked N-acetyl-D-glucosamine, which is then modified 
enzymatically in the Golgi, first through N-deacetylation and N-sulfation by N-sulfotransferases 
acting concomitantly to produce clusters of N-sulfated glucosamines in the chain. These provide 
sites for the action of subsequent enzymes, including the epimerization of D-glucuronate acid to L-
iduronate acid, O-sulfation of C-2 on iduronate residues and of C-6 and C-3 on glucosamine 
residues {Ori, 2008 #28}. The result is that modifications tend to be clustered and resemble distinct 
domains of varying dimensions known respectively as; non-sulfated (N-acetylated) domains, 
intermediate domains (NAS) domains, that have approximately one in two D-glucosamine units 
modified by N-sulfation, and sulfated domains, in which glucosamine is N-sulfated (termed S-
domains). A branched arrangement of this biosynthetic pathway, based on a disaccharide unit and 
commensurate with the abundances of experimentally observed structures, has been suggested 
recently {Rudd, 2012 #95}. The more highly sulfated regions of HS resemble heparin, but contain 
fewer O-sulfate groups, and are generally considered to provide protein binding sites {Ori, 2008 
#28}. 
 The interactions of some FGFs with HS and its derivatives have been subjected to scrutiny 
in vitro, but their levels of specificity and selectivity are actively debated, e.g., {Kreuger, 2006 
#104}. A recent biophysical analysis suggested that different FGFs bind to heparin in distinct ways 
to different, yet overlapping motifs in the polysaccharide {Xu, 2012 #47}. It has been proposed that 
a higher degree of specificity may exist at the level of the full ligand-receptor system {Guimond, 
2006 #71;Kreuger, 2006 #104}. In vitro, some specificity is evident, in particular regarding the 
preferences of FGFR for FGFs. However, the majority of FGF sub-families can support signaling 
through several receptors in the presence of heparin, as a proxy for HS {Guimond, 2006 
#71;Ornitz, 1996 #64}. This is likely to identify all the possible signaling combinations because, 
generally, the extensively sulfated heparin activates all pathways in which only a restricted set of 
forms of HS are active. In vivo ternary complexes containing the FGF, HS and FGFR can be 
formed in situ only on HS polysaccharide co-receptors from particular tissue compartments {Allen, 
2003 #105}. Thus, a higher level of selectivity is likely in vivo, owing to the lower sulfation and 
restricted sets of structures in HS.  
The expansion of FGFs and FGFRs during evolution and the pivotal regulatory role played 
by the HS co-receptor suggests that specificity may be discernible from a consideration of the 
entire system rather than individual interactions. Thus, we have analysed the properties of the 
FGF-FGFR-HS signaling system from the point of view of a simple network, in which the ability of 
a particular FGF to support signaling is represented as connecting any two or more FGFRs 
through which it can signal. Alongside, we have measured the changes in the secondary structure 
of selected FGFs that accompany their interaction with heparin to determine if these follow a 
simple pattern. 
 
Results 
 
 
 
Figure 1A. A representation of the signaling network between FGF receptors. The numbers on the 
edges represent the number of FGFs that are able to support signaling between the respective 
FGFRs in the presence of heparin. The products of the published mitogenic activities are also 
higher in the core network formed by FGFR1c, 2c, 3c and 4, than elsewhere.  
 
(i) Analysis of the FGFR signaling network. One important characteristic of the FGF-FGFR 
signaling system is its high degree of connectivity. Thus, in many cases, different FGFs are known 
to have the ability to interact with, and signal through, several FGFRs. The interactions of FGFs 
 with FGFRs have been surveyed previously in the presence of heparin in terms of both binding 
and the ability to support signaling in a cell-based assay {Ornitz, 1996 #64}. Binding events per se 
do not necessarily equate to the formation of a signaling complex, and so the data reported for 
signaling in an experimental cell-based assay of mitogenesis for FGF-1 to -9 and with receptors 
FGFR1b, 1c, 2b, 2c, 3c and 4, rather than binding were analysed. This allows a preliminary 
network to be assembled, employing approaches from discrete mathematics (graph theory), in 
which two FGFRs (represented by vertices) that both signal with a particular FGF are shown 
joined (by edges) (represented by Table 1). The ensemble of these “connections”, records the 
ability of the FGF to affect multiple points in a network and can be analysed in terms of both the 
individual FGFs and the receptors through which they signal in the presence of heparin but, more 
interestingly, also form a graph depicting connectivity between receptors (Figure 1A). This could 
represent, for example, a signaling situation that may exist between two cells supported by the 
same FGF (and HS structures), which are expressing distinct receptors, or combinations of 
receptors. It is evident that some receptors, for example, FGFR2c are more heavily connected 
than others, such as FGFR2b and the level of redundancy is noteworthy. It can also be seen that 
there is a highly connected core network, involving FGFR1c, 2c, 3c and 4, which are all 
interconnected and the connections are heavily redundant (Figure 1A). The network generated 
using this approach lends itself to analysis with tools from Graph Theory {Van Mieghem, 2010 
#99}, which demonstrates that this is a substantially connected network (Table 1). It is known, 
however, that beyond this immediate FGFR network, HS interacts with over 400 proteins {Ori, 
2011 #23} but, there is little experimental data concerning those interactions and any relation they 
may have with FGF signaling. 
 
Table 1. Relative mitogenic activity of individual exogenous FGFs on BaF3 cells lacking HS and in 
the presence of added heparin (2 µg/ml). Data are from {Ornitz, 1996 #64}, with the exception of 
the value for FGFR1c and FGF-8, which is from {Zhang, 2006 #183}, and are normalised relative 
to FGF-1 and were rounded to the nearest tenth. The FGF sub-family to which each FGF has been 
attributed, is also shown. An expander is a graph in which each vertex (or node) is connected to 
each other vertex to produce a network with the same number of connections (edges) emanating 
from each. Such graphs are extremely robust since breaking individual connections has little effect 
on their overall characteristics {Van Mieghem, 2010 #99}. Eigenvalue analysis of the matrices 
representing the full and core networks can provide a measure of their qualities, in particular, the 
difference between the first and second eigenvalues, the eigenvalue gap. Analysis of the product 
of the matrix shown in the Table with its transpose reveals a difference in the moduli of the first and 
second eigen values of (17.6-2.1=15.5), which indicates a substantially connected graph {Hoory, 
2006 #1}. 
 
   FGF-n 
  1 2 3 4 5 6 7 8 9 
Sub-family  1 1 3 4 4 4 7 8 9 
           
FGFR           
1b  1.0 0.6 0.3 0.2 0.0 0.0 0.1 0.0 0.0 
1c  1.0 1.0 0.0 1.0 0.6 0.6 0.0 0.6 0.2 
2b  1.0 0.1 0.5 0.1 0.0 0.1 0.8 0.0 0.1 
2c  1.0 0.6 0.0 0.9 0.3 0.6 0.0 0.2 0.9 
3b  1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 
3c  1.0 1.1 0.0 0.7 0.1 0.1 0.0 0.4 1.0 
4  1.0 1.1 0.1 1.1 0.1 0.8 0.0 0.8 0.8 
  
 
Figure 1B. The highly connected core network involving FGFR1c, 2c, 3c and 4. The core network 
can be differentiated into an earlier triangular sub-network (left) comprising FGFR2c, 3c and 4 
which, upon divergence of FGF subfamilies 1, 4 and 9 from the FGF-8 sub-family, and evolution of 
FGR1c, formed a 4-member core network (right). 
 
(ii) Analysis of mitogenic signaling activity of a network comprising fgfs-1 to 9 with FGF 
receptors of the core network. The data reporting the relative mitogenic activity of individual 
FGFs with FGFRs {Ornitz, 1996 #64} (Table 1) can be analysed by asking which FGFs can 
individually support signalling through pairs of FGFRs, and so form a reciprocating signaling 
network. This was done by taking the products of the two mitogenic activities between the FGFRs 
and individual FGFs (Table 2). In this sense, it is clear that FGFR1b, 2b and 3b are all rather 
poorly connected to other FGFR members, and even when they do support signaling, it is often to 
a relatively low extent. Notably, FGF-3 and -7 signal almost exclusively through these FGFRs, 
forming a sub-network, that is able to utilise FGF-3 and FGF-7, which most of the other FGFRs are 
unable to do (with the exception of FGFR4 with FGF-3, but then only weakly). Although FGF-3 has 
been reported to bind FGFR4, no mitogenic activity was reported {Ornitz, 2001 #62}. 
 
Table 2. A measure of signaling between FGFRs in the core network can be found from the 
product of the mitogenic activity of the two FGFRs (from Table 1) and the particular FGF. This 
analysis assumes that there is no direct influence exerted on signaling through a FGFR by any 
other FGFR. 
 
 FGF-n 
 1 2 3 4 5 6 7 8 9 
FGFR          
1c and 2c 1.00 0.60 0.00 0.90 0.18 0.36 0.00 0.12 0.18 
2c and 3c 1.00 0.60 0.00 0.81 0.03 0.06 0.00 0.08 0.90 
3c and 4 1.00 1.21 0.00 0.77 0.01 0.08 0.00 0.32 0.80 
1c and 4 1.00 1.10 0.00 1.10 0.06 0.48 0.00 0.48 0.16 
2c and 4 1.00 0.66 0.00 0.99 0.03 0.48 0.00 0.16 0.72 
1c and 3c 1.00 1.10 0.00 1.10 0.00 0.48 0.00 0.24 0.16 
 
Exclusion of poorly connected FGFR1b, 2b and 3b, from Table 2, reveals a core network 
(Figure 1A) with complete mutual interconnection (a complete graph) and redundancy. The 
significance of a complete graph in a signaling network is that it is extremely robust, and high 
redundancy further ensures the fidelity of the signals in this section of the network. These four 
FGFRs are generally more highly connected in terms of the number of FGFs which support 
signaling between FGFR pairs, averaging 6.8 inside the core network and 4.2 outside. 
Furthermore, the sum of their mitogenic products (taken from Table 2) inside the core network is 
~3.8 and outside is ~1.6 (ignoring crossed-terms). 
 
  
 
 
Figure 2 SRCD spectra of FGFs with different concentrations of heparin. Six FGFs and their 
heparin complexes spectra at molar ratios (FGF: heparin), 5:1, 1:1 and 1:5. A, FGF-1. B, FGF-2. 
C, FGF-7. D, FGF-9. E, FGF-18 (FGF-8 sub-family). F, FGF-21 (FGF-19 sub-family).  Spectra for 
the FGF alone and for the 1:5 molar ratio of FGF:heparin were originally published in {Xu, 2012 
#47} © the American Society for Biochemistry and Molecular Biology. 
 
Subsequent to the work of Ornitz et al., {Ornitz, 1996 #64}, Zhang et al., {Zhang, 2006 
#183} found that FGF-8 had mitogenic activity through FGFR1c [Table 1A] and this work also 
included additional members of the FGF-8 sub-family. While there is inevitably some variation in 
cell proliferation assay data between these two reports, it is interesting that the data reported in 
{Zhang, 2006 #183} for the three members of the FGF-8 subfamily (FGFs -8, -17 and -18) reveal 
very weak mitogenic activity for FGF-18 (<5% that of FGF-1) with FGFR1c, or weak to moderate 
activities for FGF-17 (23% of FGF-1) and FGF-8 (58% of FGF-1) with FGFR1c. Consequently, the 
products of mitogenic activities for combinations of FGFRs involving FGFR1c are the weakest 3 
 (with FGF-18), and 3 of the 4 weakest for both FGF-8 and FGF-17. This indicates relatively poor 
connectivity of FGFR1c via the other members of the FGF-8 subfamily, but particularly FGF-18, to 
FGFRs 2c, 3c and 4. 
 
 
 
 Figure 3 Secondary structure changes of FGFs with different concentrations of heparin. 
The secondary structures were determined for six FGFs and their heparin complexes at molar 
ratios (FGF: heparin), 5:1, 1:1 and 1:5. A, FGF-1. B, FGF-2. C, FGF-7. D, FGF-9. E, FGF-18 
(FGF-8 sub-family). F, FGF-21 (FGF-19 sub-family). Protein secondary structures were 
determined using the Dichroweb website, employing the SELCON3 algorithm with reference data 
set 3 [45, 46]. The FGF and FGF:heparin (1:5) complex secondary structures and SRCD spectra 
were originally published in {Xu, 2012 #47} © the American Society for Biochemistry and Molecular 
Biology. 
 
Interestingly, this implies two distinct regions within the core network. The connections 
between FGFR2c, 3c and 4 all involve FGF-1, -2 (subfamily 1), -4, -6 (subfamily 4), -8 (subfamily 
 8) and -9 (subfamily 9), while those to FGFR1c from all other FGFRs involve FGF-8 subfamily 
members much more weakly (Figure 1a and 1b). This suggests that divergence from this FGF 
sub-family by a common ancestor of FGFs -1, -4, -6 and -9 coupled to, or followed by co-evolution 
of FGFR1c (followed by, because FGF evolution is thought to have preceded FGFR evolution 
{Itoh, 2004 #72}) was a key event in allowing expansion of an original three member, triangular 
core network with three interconnections (Figure 1B) to a four member form, with six 
interconnections between FGFRs (Figure 1A). This provides a 4-fold increase in the number of 
possible signaling combinations (single, double, triple and quadruple). The robust four member 
form of the core network has a level of redundancy in each connection of 6 or 7 (from Table 1).  
 
(iii) SRCD spectral changes when adding different concentrations of heparin may relate to 
the number of heparin binding sites of the FGFs. In light of the above, it was of interest to 
examine the binary complexes of FGFs and heparin. The SRCD spectra of six FGFs and their 
heparin complexes were collected under identical conditions (Figure 2 A-F). The spectrum of 
FGF-18 (belonging to FGF sub-family 8) (Figure 2 E) exhibited significant changes when heparin 
was introduced, while FGF-1, -2, -7 and -9 also showed some differences (Figure 2 A-D). On the 
other hand, FGF-21 (sub-family 19), which binds heparin only very weakly {Xu, 2012 #47}, showed 
very little spectral change (Figure 2 F), confirming the lack of binding and showing that higher 
levels of heparin do not unduly alter the CD spectrum.  
Importantly, the SRCD spectra demonstrated that there was no simple trend in the structural 
changes observed in the FGFs as the concentration of heparin was increased (i.e. there was not a 
single direction of change). This is illustrated in Figure S1, where the normalised ellipticity at 203 
nm is plotted for FGF-1, -2 and -18. Thus, although structural changes depend on the presence of 
heparin, higher concentrations do not necessarily produce larger changes in secondary structure 
in a linear direction (Figure 4 and Table S1.). One trend that is apparent in the secondary 
structure data is evident for FGF-1, -2, -7 and -9. As the heparin concentration increases, so does 
the content of unordered secondary structure (Figure 4), the opposite occurs for FGF-18; the 
protein becoming markedly more structured (both strands and helices), while for FGF-21 there is 
no change presumably because it does not interact with heparin. This may be related to the 
number of binding sites for the sugar in the proteins {Ori, 2009 #26;Xu, 2012 #47}. When a small 
amount of heparin is present, most of it will bind to the canonical heparin binding site (HBS-1), 
since this has the highest affinity, initiating a particular set of conformational changes in the FGF 
ligands. As more heparin is added, the canonical heparin binding sites become saturated and the 
heparin will start binding the lower affinity HBS-2, HBS-3, and HBS-4, producing additional 
conformational changes. Whereas the canonical HBS1 is the one engaged with the sugar in 
ternary receptor complexes {Pellegrini, 2000 #81;Schlessinger, 2000 #82}, the secondary binding 
sites may have other functions, including regulation of the transport of FGFs through extracellular 
matrices {Duchesne, 2012 #39}. Therefore, the specificity and effects on FGF structure of heparin 
binding may be more convoluted than that simply required for forming a signaling complex, since it 
may reflect different functions, e.g., signaling and transport. 
 
Discussion 
 
The present work indicates that the co-evolution of FGFR1c and divergence of FGF sub-families -
1, -4 and -9 from FGF subfamily 8 may be linked to expansion of a triangular core network 
 involving FGFR2c, 3c and 4 into a four member network. This core network is highly redundant 
and this presents cells with the possibility of reliably stimulating the highly connected core network 
with particular FGFs in distinct tissues, while maintaining the fidelity of core signaling events. In 
graph terminology, this core network is a complete graph. Furthermore, it has good expander 
properties (Table 1); that is to say, each vertex is connected to each other vertex, and several 
times over, to produce a very robust system.  
 
Members of FGF subfamily 8 and the other FGFs diverged early in the evolution of 
multicellular life. The analysis suggests that expansion of the three to a four member core 
network occurred relatively early in evolution, at the stage of fgf expansion. Two-stages of fgf gene 
evolution have been postulated. The first involves fgf expansion in the early metazoan, from 3 to 6 
genes by duplication. The second, in early vertebrates, involved large-scale genome duplications. 
This is in contrast to FGFR family expansion, which occurred during the second phase only, but 
then achieved additional diversity through splice variants {Itoh, 2004 #72}. The analysis by Oulion 
et al., {Oulion, 2012 #73}, based on a systematic analysis of recently discovered gene sequences, 
proposes a re-classification of the fgf gene family into 8, rather than 7 sub-families, the notable 
difference being the allocation of FGF-3 to its own sub-family, in contrast to its usual allocation to 
sub-family-7. It is also interesting that the same analysis indicates that genes encoding the FGF-1 
sub-family (FGF-1 and-2) and FGF-8 sub-family members (FGF-8, -17, -18 and -24) were already 
present in the eumetazoan ancestor, indicating divergence of the FGF-8 subfamily from other sub-
groups at an early stage in evolution. Unlike GAG biosynthetic enzymes, fgf-like genes have not 
been identified in the unicellular choanoflagellates, postulated to represent the descendants of the 
last common unicellular ancestor of metazoa {King, 2008 #106;Ori, 2011 #23}. However, two fgf-
like genes are present in C. elegans (egl-17 and let-756) {Burdine, 1997 #45;Roubin, 1999 #43} 
and three in Drosophila; branchless, pyramus and thisbe {Gryzik, 2004 #40;Stathopoulos, 2004 
#41}, supporting their primordial origin. 
The early divergence of FGF subfamily-8 from the other FGF subfamilies has been revealed 
by analysis of amino acid sequences {Ornitz, 2001 #62} and, in light of the indications here of the 
importance of the divergence of FGF sub-family-8 for expansion of the core FGFR signalling 
network from three to four members, it is interesting that the FGFs identified in simple multicellular 
organisms resemble particular FGFs {Birnbaum, 2005 #42}. In C.elegans, the 2 FGFs, egl-17 and 
let-756 resemble FGF-8 and -9 respectively, while in Drosophila, both pyramus and thisbe 
resemble FGF-8. 
 
Heparin binding sites on FGFs overlap with FGFR binding sites. FGFs mediate their 
bioactivities by binding to their cell surface receptors, FGFR and HS, to form a signalling complex.  
It seems likely that, in vivo, FGF binds first to HS and then to the FGFR, since HS binding sites are 
several orders of magnitude more abundant in the pericellular matrix and on the cell surface 
{Duchesne, 2012 #39}. There are different numbers of HBSs evident in the FGF sub-families {Xu, 
2012 #47}. A question of interest is whether there is any overlap between these and the FGFR 
binding sites. FGF-2 has three HBSs {Baird, 1988 #38;Faham, 1996 #37;Kinsella, 1998 #35;Ori, 
2009 #26;Thompson, 1994 #36} and the residues interacting with the FGFR have been identified 
by site-directed mutagenesis {Springer, 1994 #34} and X-ray crystallography (FGF-2-FGFR1, 
PDB: 1CVS) {Plotnikov, 1999 #76}. A comparison of these binding sites indicates that HBS-3, 
towards the N-terminus, overlaps with the FGFR binding site at position K30. In addition to FGF-2, 
 other FGFs also have residues involved in both interactions. According to a recent analysis using a 
protect and label approach (Figure 2 in {Xu, 2012 #47}) and the crystal structures of heparin-FGF-
1-FGFR2 (PDB: 1E0O) {Pellegrini, 2000 #81}, K24 in HBS-3 overlaps with its FGFR. K-24 in FGF-
1 is at the equivalent position to K30 in FGF-2 when the secondary structures of these proteins are 
aligned {Xu, 2012 #47}. By sequence alignment there is a possible HBS-3 at the N-terminus of 
FGF-7, R65, but, since this only contains arginines, it was not identified by protect and label {Xu, 
2012 #47}. The sequence alignment of the FGF-7 subfamily and the FGF-10-FGFR2b crystal 
structure (PDB: 1NUN) {Yeh, 2003 #33}, shows that R78 of FGF-10 (allocated to FGF sub-family 
7) is at the equivalent position to R65 in FGF-7 and so might be part of a HBS-3 {Xu, 2012 #47}, 
which is involved in binding to FGFR {Yeh, 2003 #33}. These secondary HBS are likely to impact 
on the transport of FGFs in extracellular matrix {Duchesne, 2012 #39}. The overlap of one of 
these, HBS3 with part of the FGFR binding site may imply that a re-arrangement of FGF-sugar 
interactions is required in some instances to allow the ternary signaling complex to form.  
  
 
 
Figure 4. Normalised change in ellipticity at 203 nm for FGF bound to different ratios of heparin. 
This figure illustrates that the interaction with heparin and the protein does not follow a simple 
linear relationship. The FGF and FGF:heparin (1:5) complex secondary structures and SRCD 
spectra were originally published in {Xu, 2012 #47} © the American Society for Biochemistry and 
Molecular Biology. 
 
The interactions between FGFs and heparin/HS derivatives and analogues depend on both 
their dimensions and the nature of their charge distribution, and evidence from a variety of 
experimental methods demonstrates that charge, size and conformation are important in these 
interactions {Afratis, 2012 #130;Militsopoulou, 2003 #131}. Importantly, different sequences can, if 
the dimensions, shape and charge distribution are correct, act in the same way as heparin to 
provide a suitable co-receptor for signaling {Rudd, 2010 #189}.  A consequence may be the 
observed modulatory effect of chrondroitin sulfate on FGF signaling Nikitovic et al Int J Biochem Cell 
Biol. 2008. Interestingly, the mechanism for FGF-1 and FGF-2 have been found to be different; 
FGF-1 requiring only a saccharide capable of providing stabilisation while, in contrast, FGF-2 
required induction of the appropriate secondary structural changes before being able to support 
signaling {Rudd, 2010 #189;Xu, 2012 #47}. The SRCD spectra [Figure 2 and Figure 3] undergo 
 considerable conformational change on addition of heparin, confirming that interactions occur and 
reveal differences between FGFs. Importantly, non-linear changes are evident as the ratio of 
heparin is increased [Figure 4]. This has been studied in some detail elsewhere and indicates the 
presence of several binding sites of different affinity, which have also been mapped using a 
'Protect and Label' strategy {Xu, 2012 #47}.  
 
Appreciation of the networked signaling system will influence the choice of pharmaceutical 
targets and the nature of attempts to target this system. Assembling the signaling network in 
the present way suggests that it can be approached as an entire experimental system. There are 
increasing indications that the combinations of activities supported by particular sugar structures 
may be one way of influencing this and similar networks in a more effective way than targeting 
single interactions e.g., {Groah, 2011 #108;Lallam-Laroye, 2011 #107;Rai, 2011 #109}. This might 
be particularly relevant, because it is apparent that there is a good deal of redundancy in terms of 
FGF signaling and sugar co-receptor specificity and selectivity. Employing the network to search 
for agents capable of particular combinations of selective intervention is an attractive experimental 
and practical possibility, as is the prospect of supporting signaling patterns distinct from those 
present in the extant system.  
 The FGF/FGFR/HS signaling network presented here is only a small proportion of a much 
richer, more complex network, with which HS interacts. There will also be comparable (but 
probably subtly different) networks of FGF/FGFR connections with other HS structures and the 
variability of HS structures offers an additional dimension through which the network can be 
viewed or influenced. Presumably, HS structures with lower sulfation levels will tend to induce 
restricted networks, although this remains largely untested. It will also be interesting to compare 
heparin binding sites and their affinities to those of different HS structures. 
Highly complex signaling networks exist at the heart of cell signalling and both the 
FGF/FGFR system and HS are key players, interacting with many hundreds of other components. 
Such systems can be prone to noise, as well as being sensitive to small fluctuations causing wider 
disruption. It is important, therefore, for the network to have built-in stability against such 
sensitivity. If the core, highly connected network is viewed as serving to transmit a particular range 
of signals, rather than any individual ones, it is closely analogous to a communication network and 
can be termed an expander graph {Hoory, 2006 #1}, a term coined in the field of 
telecommunications, which describes the degree to which a network is inter-connected and 
reflects its resulting degree of stability. Such expanders conserve the fidelity of patterns of 
information transfer against noise, in this context, ensuring that the correct set of coordinated 
signals is transmitted.  Consequently, the redundancy noted above is likely to reflect the need for 
such robustness. 
 Clearly, more refined data, in which the strength of signalling with other interacting proteins 
{Ori, 2008 #28} is included, will be required for a fuller treatment. A more complete description of 
this signaling system will need to incorporate the affinity of each component and take into account 
multiple, and potentially overlapping, binding sites. Future refinements will entail extension of the 
network to incorporate other proteins that interact with FGFs and FGFRs either directly, e.g., 
{Murakami, 2008 #20}, or indirectly through HS. Importantly, more extensive networks would 
provide data concerning which other receptors may be influenced and the likely capacity of the 
system to provide compensatory signaling pathways. A probable outcome of this approach will be 
the realisation that it will be necessary to inhibit (or stimulate) several events simultaneously and 
 the network does provide an experimental framework for screening compounds to this end.  This 
would increase the discovery rate of such compounds, which have intriguing activities in animal 
models and patents, but for which there are just a few examples {Groah, 2011 #108;Lallam-
Laroye, 2011 #107;Rai, 2011 #109}. 
 
Experimental procedures 
 
FGF expression and purification:- FGF-1 (UniProt Accession: P05230; residues: 16-155) and 
FGF-2 (UniProt Accession: P09038-2; residues: 1-155) were cloned into a vector pET-14b 
(Novagen, Merck Chemical Ltd, Nottingham, UK) and purified as described {Ke, 1992 
#15;Uniewicz, 2010 #12}. cDNAs encoding FGF-7 (Uniprot Accession: P21781; residues: 32-194), 
FGF-9 (Uniprot Accession: P31371; residues: 1-208), FGF-18 (zFGF5) (UniProt Accession: 
O76093; residues: 28-207) and FGF-21 (Uniprot Accession: Q9NSA1; residues: 29-209) were 
inserted separately into a modified pET-24b vector (pETM-11, kind gift of Dr. Paul Elliott, University 
of Liverpool), and they were purified as described {Ke, 1992 #15;Uniewicz, 2010 #12;Xu, 2012 
#47}.  
 
Synchrotron radiation circular dichroism (SRCD) spectroscopy:- FGFs were buffer 
exchanged into CD buffer (15.3 mM Na2HPO4, 2.2 mM NaH2PO4, pH 7.5). Six different FGFs 
(FGF-1, -2, -7, -9, -18 and -21) at a concentration of 0.5 mg/ml (FGF-1, -2, -7, -18 and -21) or 1 
mg/mL (FGF-9) and heparin (17 kDa average molecular weight, Celsus Lab, Cincinnati, OH, USA: 
disaccharide composition (%): ΔUA-GlcNAc; 5.8, ΔUA-GlcNAc; 8.4, ΔUA-GlcNS; 2.1, ΔUA-
GlcNS(6S); 22.9, ΔUA(2S)-GlcNS; 9.0, ΔUA(2S)-GlcNS(6S); 49.5, ΔUA(2S)-GlcNAc; 0.6, 
ΔUA(2S)-GlcNAc(6S),1.7 (data from {Skidmore, 2006 #153}) were mixed in different ratios (1:5-
5:1) and then loaded into a quartz cuvette (Hellma UK Ltd, Southend on Sea  , Essex, UK) path 
length 0.2 mm, and the SRCD spectra were acquired from 178 nm to 260 nm on beam line B23, 
Diamond Light Source Ltd. {Hussain, 2012 #100}, as described {Xu, 2012 #47}. Heparin binds 
FGF-21 (sub-family 19) only very weakly and showed very little spectral change (Figure 2 F) on 
addition of heparin at any of the concentrations tested. This confirms both the lack of binding and 
that higher levels of heparin do not provide significant CD spectral features in this experimental 
set-up. Protein secondary structures were determined using the Dichroweb website, employing the 
SELCON3 algorithm with reference data set 3 {Whitmore, 2004 #118;Whitmore, 2008 #113}. 
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ΔUA(2S); 4,5 unsaturated, 2-O-sulfated uronate residue. ΔUA; 4,5 unsaturated uronate residue. 
FGF; fibroblast growth factor. fgf: the gene encoding a fibroblast growth factor. FGFR; fibroblast 
growth factor receptor. GAG; glycosaminoglycan. HBS; heparin binding site. HS; heparan sulfate. 
HSPG; heparan sulfate proteoglycan. GlcNAc; N-acetyl glucosamine. GlcNAc(6S); N-acetyl 
glucosamine, 6-O-sulfate. GlcNS; N-sulfamino glucosamine. GlcNS(6S);  N-sulfamino, 6-O-
sulfated glucosamine. NAS-domain; intermediate domain of heparan sulfate. S-domain; sulfated 
domain of heparan sulfate. SRCD; synchrotron radiation circular dichroism. 
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